TY - JOUR
T1 - Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products
AU - Miyata, Toshio
AU - Iida, Yoshiyasu
AU - Ueda, Yasuhiko
AU - Shinzato, Toru
AU - Seo, Hisao
AU - Monnier, Vincent M.
AU - Maeda, Kenji
AU - Wada, Yoshinao
N1 - Funding Information:
and critiques of the manuscript. This study was supported in part by a
Funding Information:
grant from the Ministry of Education, Science, and Culture of Japan, and a grant from Baxter Extramural Grant Program.
PY - 1996
Y1 - 1996
N2 - We recently found that acidic β2-microglobulin (β2m), a major isoform of β2m in amyloid fibrils of patients with dialysis-related amyloidosis (DRA), contained early Amadori prod ucts and advanced glycation end products (AGEs) formed nonenzymatically between sugar and protein. Further analysis revealed that acidic β2m induces monocyte chemotaxis and macrophage secretion of bone-resorbing cytokines, suggesting the involvement of acidic β2m in the pathogenesis of DRA. Acidic β2m, however, is a mixture of heterogeneous molecular adducts due to various types of modification. In the present study, we investigated the modification responsible for the biological activity of acidic β2m toward monocytes/macrophages. The presence of a fair amount of β2m species with deamidation was detected in acidic β2m isolated from urine of non-diabetic long-term hemodialysis patients, but deamidated β2m had no biological activity. In contrast, normal β2m acquired the activity upon incubation with glucose in vitro. Among the glycated β2m, the pigmented and fluorescent β2m that formed after a long incubation period, that is, AGE-modified β2m, exhibited biological activity, whereas p,m modified with Amadori products, major Maillard products in acidic β2m, had no such activity. These findings suggest that AGEs, although only a minor constituent of acidic β2m, are responsible for monocyte chemotaxis and macrophage secretion of cytokines, implicating the contribution of AGEs to bone and joint destruction in DRA.
AB - We recently found that acidic β2-microglobulin (β2m), a major isoform of β2m in amyloid fibrils of patients with dialysis-related amyloidosis (DRA), contained early Amadori prod ucts and advanced glycation end products (AGEs) formed nonenzymatically between sugar and protein. Further analysis revealed that acidic β2m induces monocyte chemotaxis and macrophage secretion of bone-resorbing cytokines, suggesting the involvement of acidic β2m in the pathogenesis of DRA. Acidic β2m, however, is a mixture of heterogeneous molecular adducts due to various types of modification. In the present study, we investigated the modification responsible for the biological activity of acidic β2m toward monocytes/macrophages. The presence of a fair amount of β2m species with deamidation was detected in acidic β2m isolated from urine of non-diabetic long-term hemodialysis patients, but deamidated β2m had no biological activity. In contrast, normal β2m acquired the activity upon incubation with glucose in vitro. Among the glycated β2m, the pigmented and fluorescent β2m that formed after a long incubation period, that is, AGE-modified β2m, exhibited biological activity, whereas p,m modified with Amadori products, major Maillard products in acidic β2m, had no such activity. These findings suggest that AGEs, although only a minor constituent of acidic β2m, are responsible for monocyte chemotaxis and macrophage secretion of cytokines, implicating the contribution of AGEs to bone and joint destruction in DRA.
UR - http://www.scopus.com/inward/record.url?scp=0030026971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030026971&partnerID=8YFLogxK
U2 - 10.1038/ki.1996.77
DO - 10.1038/ki.1996.77
M3 - Article
C2 - 8821842
AN - SCOPUS:0030026971
VL - 49
SP - 538
EP - 550
JO - Kidney International
JF - Kidney International
SN - 0085-2538
IS - 2
ER -